Colgate-Palmolive (NYSE:CL) Given New $95.00 Price Target at Stifel Nicolaus

Colgate-Palmolive (NYSE:CL) had its target price trimmed by Stifel Nicolaus from $101.00 to $95.00 in a research report report published on Friday morning,Benzinga reports. The firm currently has a hold rating on the stock.

Several other equities analysts have also recently issued reports on CL. UBS Group decreased their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research note on Thursday. TD Cowen decreased their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Barclays dropped their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. dropped their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a report on Thursday. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $101.11.

Colgate-Palmolive Trading Up 0.3 %

Shares of NYSE:CL opened at $88.79 on Friday. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12-month low of $79.69 and a 12-month high of $109.30. The business has a 50 day moving average of $92.27 and a two-hundred day moving average of $97.78. The company has a market capitalization of $72.55 billion, a PE ratio of 25.44, a PEG ratio of 3.01 and a beta of 0.44.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.37% of the company’s stock.

Institutional Investors Weigh In On Colgate-Palmolive

A number of hedge funds have recently modified their holdings of the company. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at about $42,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive in the third quarter valued at approximately $53,000. Prospera Private Wealth LLC purchased a new position in Colgate-Palmolive in the third quarter worth approximately $64,000. True Wealth Design LLC grew its position in Colgate-Palmolive by 1,460.9% in the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after acquiring an additional 672 shares during the period. Finally, Continuum Advisory LLC increased its stake in Colgate-Palmolive by 93.4% during the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after acquiring an additional 368 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.